Company Valuation: MedPacto, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 2,393,411 1,201,906 469,045 243,124 152,010 228,958
Change - -49.78% -60.97% -48.17% -37.48% 50.62%
Enterprise Value (EV) 1 2,348,548 1,080,523 435,468 172,948 98,472 189,985
Change - -53.99% -59.7% -60.28% -43.06% 92.93%
P/E -94.2x -70.4x -13x -4.35x -7.42x -17.9x
PBR 43x 27.6x 14.5x 3.43x 2.63x 4.98x
PEG - 2.1x -0x 1.85x 0.1x 0.5x
Capitalization / Revenue - - - - - 58,730,052x
EV / Revenue - - - - - -
EV / EBITDA -89.1x -39x -12.3x -6.42x -4.86x -14.7x
EV / EBIT -84.5x -36.7x -11.7x -6.02x -4.52x -13.5x
EV / FCF - - - - - -
FCF Yield - - - - - -
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -1,249 -832.3 -1,705 -1,665 -598 -373.8
Distribution rate - - - - - -
Net sales - - - - - 3,898
EBITDA 1 -26,363 -27,736 -35,380 -26,919 -20,265 -12,888
EBIT 1 -27,800 -29,459 -37,246 -28,752 -21,807 -14,044
Net income 1 -25,352 -17,040 -35,753 -35,325 -20,140 -12,811
Net Debt 1 -44,863 -121,383 -33,577 -70,177 -53,538 -38,973
Reference price 2 117,700.00 58,600.00 22,250.00 7,240.00 4,435.00 6,680.00
Nbr of stocks (in thousands) 20,335 20,510 21,081 33,581 34,275 34,275
Announcement Date 3/14/22 3/14/22 3/13/23 3/20/24 3/20/25 3/18/26
1KRW in Million2KRW
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 67.77M
35.02x8.81x27.34x0.05% 57.72B
19.79x6.09x13.27x1.53% 52.65B
-42.68x14.17x-41.28x-.--% 24.46B
-18.74x4.62x-8.07x-.--% 23.84B
24.1x4.75x12.43x-.--% 19.28B
24.43x4.87x15.9x-.--% 17.8B
51.77x21.11x56.65x0.05% 17.29B
-536.63x36.92x-4116.16x-.--% 15.28B
17.96x5.22x12.19x-.--% 14.35B
Average -47.22x 11.84x -447.53x 0.18% 24.27B
Weighted average by Cap. -18.86x 10.17x -247.89x 0.35%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. A235980 Stock
  4. Valuation MedPacto, Inc.